THE SIGNIFICANCE OF INTRINSIC SYMPATHOMIMETIC ACTIVITY (ISA) OF BETA-BLOCKERS FOR ITS EFFECT ON HUMAN-LYMPHOCYTE BETA-2 ADRENOCEPTOR (R) DENSITY

被引：0

作者：

DAUL, A

SCHEMUTH, R

BRINKMANN, M

BOCK, KD

BORCHARD, U

BRODDE, OE

机构：

[1] UNIV ESSEN GESAMTHSCH,MED KLIN & POLIKLIN,DIV RENAL & HYPERTENS DIS,D-4300 ESSEN 1,FED REP GER

[2] UNIV DUSSELDORF,INST PHARMACOL,D-4000 DUSSELDORF 1,FED REP GER

来源：

JOURNAL OF HYPERTENSION | 1985年 / 3卷 / 04期

关键词：

D O I：

10.1097/00004872-198508000-00022

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：400 / 401

页数：2

共 50 条

[41] EFFECTS OF THE R(+)-ISOMERS AND S(-)-ISOMERS OF BETA-ADRENOCEPTOR BLOCKERS WITH INTRINSIC SYMPATHOMIMETIC ACTIVITY, BEFUNOLOL AND CARTEOLOL, ON RABBIT INTRAOCULAR-PRESSURE
TAKAYANAGI, I
HAGIWARA, H
KOIKE, K
HOSOKAWA, T
KASUYA, Y
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1991, 69 (08) : 1243 - 1245
[42] INTRINSIC SYMPATHOMIMETIC ACTIVITY (ISA) BLUNTS EFFECT OF BETA-BLOCKADE ON RENIN AT REST BUT NOT DURING EXERCISE
KOSTIS, JB
RUDDY, M
WARNER, RG
BIALY, G
KRIEGER, SD
COSGROVE, N
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 7 (02) : A26 - A26
[43] RELATIVE POTENCIES OF VARIOUS BETA-ADRENOCEPTOR ANTAGONISTS (BAA) AT THE LEVEL OF THE HUMAN MYOCARDIAL BETA-ADRENOCEPTOR ADENYLATE-CYCLASE (AC) COMPLEX - IS INTRINSIC SYMPATHOMIMETIC ACTIVITY (ISA) DUE TO AC ACTIVATION
GOLF, S
HANSSON, V
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1986, 46 (02): : 121 - 130
[44] CARTEOLOL, A BETA-ADRENOCEPTOR ANTAGONIST WITH INTRINSIC SYMPATHOMIMETIC ACTIVITY (ISA), REDUCES BLOOD-PRESSURE AND LEFT-VENTRICULAR HYPERTROPHY
ROSALES, OR
SANDER, GE
GIVEN, MB
GILES, TD
CLINICAL RESEARCH, 1986, 34 (01): : A190 - A190
[45] Beta-blockers modulate a portal hypotensive effect of hepatic arterial flow on portal pressure through beta-2 adrenoceptors
Ripoll, C.
Zipprich, A.
D'Silva, I.
Groszmann, R.
JOURNAL OF HEPATOLOGY, 2008, 48 : S105 - S105
[46] INTRINSIC SYMPATHOMIMETIC ACTIVITY IN BETA-BLOCKERS - THE IMPORTANCE OF BASAL HEART-RATE REDUCTION IN THE TREATMENT OF DAY TIME AND NOCTURNAL ANGINA
QUYYUMI, AA
WRIGHT, C
BEALING, L
FOX, KM
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1984, 3 (02) : 577 - 577
[47] INTRINSIC SYMPATHOMIMETIC ACTIVITY IN BETA-BLOCKERS - THE IMPORTANCE OF BASAL HEART-RATE REDUCTION IN THE TREATMENT OF DAY TIME AND NOCTURNAL ANGINA
FOX, KM
QUYYUMI, AA
WRIGHT, C
BEALING, L
BRITISH HEART JOURNAL, 1984, 51 (01): : 108 - 108
[48] LEFT-VENTRICULAR FUNCTION AND BETA-BLOCKERS - DOES INTRINSIC SYMPATHOMIMETIC ACTIVITY HAVE ANY INFLUENCE DURING CHRONIC THERAPY
NORTHCOTE, RJ
COOKE, MBD
BALLANTYNE, D
CARDIOVASCULAR DRUGS AND THERAPY, 1988, 2 (04) : 549 - 560
[49] INTRINSIC SYMPATHOMIMETIC ACTIVITY OF BETA-ADRENOCEPTOR ANTAGONISTS - DOWN-REGULATION OF CARDIAC BETA-1-ADRENOCEPTORS AND BETA-2-ADRENOCEPTORS
REITHMANN, C
WIELAND, F
JAKOBS, KH
WERDAN, K
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 170 (03) : 243 - 255
[50] REVERSAL OF AGONIST-INDUCED HUMAN-LYMPHOCYTE BETA-2-ADRENOCEPTOR DESENSITIZATION BY PREDNISONE AND KETOTIFEN
BRINKMANN, M
BRODDE, OE
DAUL, A
OHARA, N
SCHEMUTH, R
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (04) : P587 - P588

← 1 2 3 4 5 →